• Global pharmacopoeia column market size was valued at USD 443 million in 2024. The market is projected to grow from USD 480 million in 2025 to USD 789 million by 2032, exhibiting a CAGR of 8.7% during the forecast period.
Email:
Report Studies
• A pharmacopoeia column refers to a specialized chromatography column designed to meet stringent pharmaceutical quality standards documented in official pharmacopoeias such as USP, EP, or JP. These high-performance liquid chromatography (HPLC) columns play a critical role in drug purity testing, stability studies, and quality control processes by ensuring compliance with regulatory requirements for pharmaceuticalcompounds.
Email: help@intelmarketresearch.com +91 9169164321
By Types
• Pharmaceutical • Biotechnology • Food Safety • Others
• Regional Analysis: Pharmacopoeia
Key Players :
•Agilent Technologies, Inc. (U.S.)
•Waters Corporation (U.S.)
•Dikma Technologies (China)
•Shimadzu Corporation (Japan)
•Thermo Fisher Scientific (U.S.)
•Danaher Corporation (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
